Verified Nov 2026
Other
·

Roswell, Georgia
·
Since 2013
Sebela Pharmaceuticals is a specialty pharmaceutical company based in Roswell, Georgia, founded in 2013, with approximately 250 employees and estimated revenue between $100–250 million. The company develops and manufactures prescription products in gastroenterology and women's health, including colonoscopy preparation solutions, acid reflux therapies, and MIUDELLA, a hormone-free copper intrauterine device. Operations include a major research and manufacturing center in Braintree, Massachusetts.
Sebela Pharmaceuticals Inc. at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
2013
Headquarters
Roswell, Georgia
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Sebela Pharmaceuticals is a specialty pharmaceutical company based in Roswell, Georgia, founded in 2013, with approximately 250 employees and estimated revenue between $100–250 million. The company develops and manufactures prescription products in gastroenterology and women's health, including colonoscopy preparation solutions, acid reflux therapies, and MIUDELLA, a hormone-free copper intrauterine device. Operations include a major research and manufacturing center in Braintree, Massachusetts.
At a glance
Attribute | Detail |
|---|---|
Founded | 2013 |
Headquarters | Roswell, Georgia |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
What Sebela Pharmaceuticals Inc. makes
The company manufactures prescription bowel preparation solutions, a potassium-competitive acid blocker for gastroesophageal reflux disease, and MIUDELLA, a hormone-free long-acting reversible contraceptive device.
Latest developments
2026-10-12 — News and Events: Sebela Pharmaceuticals (sebelapharma.com)
2026-06-22 — Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device | Organon (organon.com)
2026-05-05 — Sebela Pharmaceuticals News and Press Releases | PR Newswire (prnewswire.com)
2026-02-24 — Organon pays $27.5M upfront for Sebela's hormone-free copper IUD (fiercebiotech.com)
2026-02-23 — Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device | Organon (organon.com)
2025-11-24 — Eversheds Sutherland advises Azurity Pharmaceuticals on Acquisition of Sebela’s Bowel Prep Franchise | Client News (eversheds-sutherland.com)
Company details
Sebela has raised over $316 million in funding and operates through a dual-hub model spanning Massachusetts and Georgia to serve gastroenterology and women's health markets. Sebela Pharmaceuticals Inc. was founded in 2013, has an estimated 200-500 employees, and is headquartered in Roswell, Georgia.
Frequently asked questions
What does Sebela Pharmaceuticals Inc. do?
Sebela Pharmaceuticals is a specialty pharmaceutical company based in Roswell, Georgia, founded in 2013, with approximately 250 employees and estimated revenue between $100–250 million. The company develops and manufactures prescription products in gastroenterology and women's health, including colonoscopy preparation solutions, acid reflux therapies, and MIUDELLA, a hormone-free copper intrauterine device. Operations include a major research and manufacturing center in Braintree, Massachusetts.
Where is Sebela Pharmaceuticals Inc. headquartered?
Sebela Pharmaceuticals Inc. is headquartered in Roswell, Georgia (645 Hembree Pkwy, Roswell, Georgia, 30076).
When was Sebela Pharmaceuticals Inc. founded?
Sebela Pharmaceuticals Inc. was founded in 2013.
How big is Sebela Pharmaceuticals Inc.?
Sebela Pharmaceuticals Inc. has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
